CRWF is an independent research company with two locations in Florida, Clearwater and Tampa. As an industry leader in clinical research, CRWF has experience in conducting over 700 research studies in various therapeutic areas, Phases I-IV. At CRWF, clinical research studies are conducted by board certified/eligible physicians, in conjunction with our medically trained staff. CRWF Continue Reading »
Are you interested in taking part in a new research study of an investigational drug for Crohn’s Disease? To pre-qualify for this study, you must: Be 18 years or older Have confirmed diagnosis of Crohn’s Disease Have Crohn’s Disease symptoms for at least 3 months Study participants will receive: Study drug at no cost Study-related Continue Reading »
Now Enrolling About Lupus More than two million individuals in North America have systemic lupus erythematosus (SLE). SLE can occur at any age in either sex. Among adults with SLE, women are 10-15 times more likely to be affected than adult men. Symptoms Achy and swollen joints Fever more than 100 degrees (F) Prolonged or Continue Reading »
Does this describe you? Consider the following criteria for possible participation in a local clinical research study: Men 50 years of age or older Women 55 years of age of older Diagnosed with gout History of major cardiovascular disease (includes stroke, blocked arteries, diabetes) Qualified participants will receive study medication and study-related medical care at Continue Reading »
Has smoking damaged your lungs? If so, you may qualify for a research study on a new treatment for COPD. Ask Your Doctor About Joining the ABLE Study. A New Research Study for People Who Have Chronic Obstructive Pulmonary Disease (COPD) You may qualify if you: Have COPD Are at least 40 years of age Continue Reading »
The Clearwater location of CRWF is currently in the process of building an 8,000 square foot building that will feature state of the art equipment and amenities for both patients and staff. In addition to the enhancements on the main CRWF building, an additional stand alone Phase 1 Unit with 6 beds is currently under Continue Reading »